64942-62-7

Basic information

• Product Name: 3-Phenyl-5,6-dichloropyridazine
• Synonyms: 3,4-Dichloro-6-phenylpyridazine;3-Phenyl-5,6-dichloropyridazine
• CAS NO: 64942-62-7
• Molecular Formula: C₁₀H₆Cl₂N₂
• Molecular Weight: 225.077
• Mol File: 64942-62-7.mol
• Article Data: 6

Chemical Properties

• Melting Point: 164-165°
• Boiling Point: 406.7±40.0 °C(Predicted)
• Appearance: /
• Density: 1.363
• Storage Temp.: 2-8°C
• PKA: -1.19±0.10(Predicted)
• CAS DataBase Reference: 3-Phenyl-5,6-dichloropyridazine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Phenyl-5,6-dichloropyridazine(64942-62-7)
• EPA Substance Registry System: 3-Phenyl-5,6-dichloropyridazine(64942-62-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 64942-62-7(Hazardous Substances Data)

Usage

General Description

3-Phenyl-5,6-dichloropyridazine is a chemical compound with a molecular formula of C11H6Cl2N2. 3-Phenyl-5,6-dichloropyridazine falls under the category of pyridazines which are organic compounds and heterocyclic aromatic ring structures with two nitrogen atoms acting as the heteroatoms. The 3-Phenyl-5,6-dichloropyridazine compound specifically has additional functional groups including a phenyl group and two chlorine atoms. The presence of these functional groups could significantly affect the compound's chemical behavior. Information regarding its specific applications is limited, highlighting the need for further research into its potential uses in various industries or scientific fields.

Upstream product

• 1011-46-7 6-phenyl-2,3,4,5-tetrahydropyridazin-3-one 
• 87769-64-0 4,5,-dihydro-6-phenyl-2-(phenylmethyl)-3(2H)-pyridazinone 
• 2051-95-8 succinylbenzene 

Downstream Products

• 89868-05-3 4-(3-Chloro-6-phenyl-pyridazin-4-yl)-thiomorpholine 
• 89868-03-1 3-Chloro-4-(4-methyl-piperazin-1-yl)-6-phenyl-pyridazine 
• 89868-13-3 3-chloro-6-phenylpyridazin-4-ol 
• 886208-50-0 3-chloro-6-phenyl-4-(pyridin-4-yl)pyridazine 
• 886208-45-3 4-chloro-2-(methoxymethyl)-6-phenylpyridazin-3(2H)-one 
• 89868-12-2 4-(4-Methyl-piperazin-1-yl)-6-phenyl-2H-pyridazin-3-one; hydrochloride 
• 89868-10-0 6-Phenyl-4-thiomorpholin-4-yl-2H-pyridazin-3-one 
• 89868-11-1 4-Morpholin-4-yl-6-phenyl-2H-pyridazin-3-one 
• 89868-09-7 4-Butylamino-6-phenyl-2H-pyridazin-3-one 
• 89868-07-5 4-(dimethylamino)-6-phenyl-3(2H)-pyridazinone 
• 89868-15-5 3-(dimethylamino)-6-phenyl-4-pyridazinol 
• 89868-16-6 6-phenyl-4-pyridazol 
• 2166-31-6 6-phenylpyridazin-3(2H)-one 
• 1026796-72-4 [6-oxo-3-phenyl-5-(2-pyridin-2-yl-ethylamino)-6H-pyridazin-1-yl]-acetic acid ethyl ester 

Relevant articles and documents

HETEROCYCLIC COMPOUND AND USE THEREOF

The present invention aims to provide a compound having a PDE inhibitory action and useful as a medicament for the prophylaxis or treatment of schizophrenia and the like. A compound represented by the formula (1x): wherein each symbol is as des

FORMULATIONS CONTAINING PYRIDAZINE COMPOUNDS

The invention relates to chemical compounds, compositions and methods of making and using the same. In particular, the invention provides selected pyridazine compounds of the formula I are independently hydrogen, hydroxyl, alkyl, alkenyl, alkynyl, alkylene, alkenylene, alkoxy, alkenyloxy, cycloalkyl, cycloalkenyl, cycloalkynyl, cycloalkoxy, aryl, aryloxy, arylalkoxy, aroyl, heteroaryl, heterocyclic, acyl, acyloxy, amino, imino, azido, thiol, thioalkyl, thioalkoxy, thioaryl, nitro, cyano, halo, sulfate, sulfenyl, sulfinyl, sulfonyl, sulfonate, sulfoxide, silyl, silyloxy, silylalkyl, silylthio, ═O, ═S, phosphonate, ureido, carboxyl, carbonyl, carbamoyl, or carboxamide; and X is optionally substituted pyrimidinyl or pyridazinyl, an isomer, a pharmaceutically acceptable salt, or derivative thereof. The invention additional relates to compositions comprising the compounds, and methods of using the compounds and compositions for modulation of cellular pathways, for treatment or prevention of inflammatory diseases, for research, drug screening, and therapeutic applications.

COMPOSITIONS AND TREATMENTS USING PYRIDAZINE COMPOUNDS AND SECRETASES

The invention relates to compositions, conjugates and methods comprising pyridazine compounds and secretase inhibitors for modulation of cellular pathways (e.g., signal transduction pathways), for treatment or prevention of inflammatory diseases (e.g., Alzheimer's disease), for research, drug screening, and therapeutic applications.